Earnings Feed
Sign Up
Home/Companies/NTLA
IIntellia Therapeutics, Inc. logo
NTLA//CIK 0001652130

Intellia Therapeutics, Inc.

SIC 2835In Vitro & In Vivo Diagnostic Substancesoperating
Add to watchlist
SEC EDGAR

Exchange

Nasdaq

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

Market Data

Dec 5, 9:30 AM ET
$9.61−$3.96 (−29.18%)

NTLA · Last trade

Prev Close

$13.57

Range (29d)

$8.04 – $12.32

$8.00$10.00$12.00$14.00Nov 6Nov 17Nov 25Dec 5

Recent Filings

1 item

Insiders

7

Tickers

Addresses

  • business

    40 ERIE STREET SUITE 130

    CAMBRIDGE, MA, 02139

  • mailing

    40 ERIE STREET SUITE 130

    CAMBRIDGE, MA, 02139

Related In Vitro & In Vivo Diagnostic Substances Companies

MYGN

MYRIAD GENETICS INC

MYGN

CDIO

Cardio Diagnostics Holdings, Inc.

CDIO

View all In Vitro & In Vivo Diagnostic Substances companies →